2022 annual financial data
Summit Therapeutics 2022 Operating margin
Direct answer
Operating margin was -10,225.39%.
Operating income was -59,633,462 GBP and net income was -65,170,046 GBP.
Operating cash flow was -33,897,438 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 583,190 GBP
- Operating income
- -59,633,462 GBP
- Net income
- -65,170,046 GBP
- Operating cash flow
- -33,897,438 GBP